S&P 500   2,981.46 (+0.52%)
DOW   26,933.32 (+0.54%)
QQQ   192.19 (+0.58%)
FB   186.41 (+1.71%)
MSFT   140.58 (+0.74%)
GOOGL   1,225.81 (+0.66%)
AMZN   1,746.81 (+0.60%)
CGC   19.99 (+5.99%)
NVDA   192.60 (+3.25%)
MU   45.09 (+0.51%)
BABA   173.68 (+1.47%)
GE   8.65 (-0.92%)
TSLA   255.80 (-0.45%)
AMD   30.34 (-0.62%)
T   37.52 (+0.13%)
F   8.88 (+0.57%)
ACB   3.72 (+5.98%)
PRI   121.74 (+0.22%)
NFLX   284.14 (-0.49%)
BAC   29.22 (+0.27%)
GILD   64.76 (+0.39%)
DIS   129.55 (-0.12%)
S&P 500   2,981.46 (+0.52%)
DOW   26,933.32 (+0.54%)
QQQ   192.19 (+0.58%)
FB   186.41 (+1.71%)
MSFT   140.58 (+0.74%)
GOOGL   1,225.81 (+0.66%)
AMZN   1,746.81 (+0.60%)
CGC   19.99 (+5.99%)
NVDA   192.60 (+3.25%)
MU   45.09 (+0.51%)
BABA   173.68 (+1.47%)
GE   8.65 (-0.92%)
TSLA   255.80 (-0.45%)
AMD   30.34 (-0.62%)
T   37.52 (+0.13%)
F   8.88 (+0.57%)
ACB   3.72 (+5.98%)
PRI   121.74 (+0.22%)
NFLX   284.14 (-0.49%)
BAC   29.22 (+0.27%)
GILD   64.76 (+0.39%)
DIS   129.55 (-0.12%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Corcept TherapeuticsAlder BiopharmaceuticalsPacira BiosciencesMadrigal PharmaceuticalsSupernus Pharmaceuticals
SymbolNASDAQ:CORTNASDAQ:ALDRNASDAQ:PCRXNASDAQ:MDGLNASDAQ:SUPN
Price Information
Current Price$14.08$18.91$36.58$84.28$25.16
52 Week RangeBuyHoldBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyHoldBuyBuyBuy
Consensus Price Target$15.75$18.44$55.67$177.00$54.71
% Upside from Price Target11.83% upside-2.47% downside52.20% upside110.01% upside117.47% upside
Trade Information
Market Cap$1.60 billion$1.58 billion$1.57 billion$1.30 billion$1.36 billion
Beta1.392.641.111.091.61
Average Volume754,1227,253,7551,271,148196,517577,098
Sales & Book Value
Annual Revenue$251.25 million$1.62 million$337.28 millionN/A$408.90 million
Price / Sales6.37978.394.51N/A3.23
Cashflow$0.65 per shareN/A$0.93 per shareN/A$2.39 per share
Price / Cash21.52N/A39.43N/A10.54
Book Value$2.39 per share$1.61 per share$7.81 per share$30.99 per share$8.67 per share
Price / Book5.8911.744.68N/A2.90
Profitability
Net Income$75.41 million$-296,430,000.00$-470,000.00$-32,810,000.00$110.99 million
EPS$0.60($4.87)$0.29($2.22)$2.05
Trailing P/E Ratio23.47N/A126.12N/A12.27
Forward P/E Ratio14.82N/A27.92N/A13.24
P/E GrowthN/AN/A$1.73N/A$0.91
Net Margins29.16%N/A2.04%N/A25.66%
Return on Equity (ROE)27.97%-226.13%8.62%-11.62%22.36%
Return on Assets (ROA)24.84%-66.86%3.90%-11.38%10.52%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A1.74%0.99%N/A0.70%
Current Ratio7.66%8.94%4.75%38.06%2.72%
Quick Ratio7.49%8.94%4.12%38.06%2.53%
Ownership Information
Institutional Ownership Percentage75.17%N/A99.10%61.78%99.12%
Insider Ownership Percentage15.50%15.40%5.80%47.69%6.57%
Miscellaneous
Employees16620251817448
Shares Outstanding113.69 million83.84 million41.63 million15.43 million52.45 million
Next Earnings Date11/7/2019 (Estimated)11/4/2019 (Estimated)11/7/2019 (Estimated)11/5/2019 (Estimated)11/5/2019 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable
 Corcept TherapeuticsAlder BiopharmaceuticalsPacira BiosciencesMadrigal PharmaceuticalsSupernus Pharmaceuticals

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel